Classys
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Classys makes medical devices used in aesthetic clinics to tighten skin and reshape facial contours without surgery, using energy-based technologies such as focused ultrasound, radiofrequency, microneedle radiofrequency, and laser.
Its devices and the consumables required to operate them are supplied to clinics, hospitals, and distributors across more than eighty countries worldwide. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company's portfolio spans its Ultraformer, Volnewmer, Everesse, Quadessy, and reepot device lines, covering the main categories of energy-based aesthetic treatment.
Summary is AI-generated and may contain errors · figures from DART filings
Alongside device sales, consumables, single-use items required each time a machine is operated, form a distinct and recurring revenue category as the installed base of devices grows.
Classys in five facts
What does Classys do?
Classys makes medical devices used in aesthetic clinics to tighten skin and reshape facial contours without surgery, using energy-based technologies such as focused ultrasound, radiofrequency, microneedle radiofrequency, and laser.
Where is Classys listed and in which sector?
Classys (Korean name: 클래시스) trades under KRX code 214150 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Classys?
Its market capitalisation was US$1.4B on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Classys's latest annual revenue and operating profit?
For fiscal year 2025, Classys reported revenue of US$254.2M, operating profit of US$128.8M and net income of US$99.6M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was up 38.6% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Investor relations (IR) meetingOct 6
- Investor relations (IR) meetingSep 28
- Investor relations (IR) meetingSep 15
- Investor relations (IR) meetingSep 9
- Report on large shareholdings (5% rule) (abbreviated)Sep 3
- Investor relations (IR) meetingSep 1
- Operating results (consolidated) (preliminary) (fair disclosure)
Classys filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$74.5M (+26.7% year on year), operating profit of US$31M (+2.2% year on year) and net income of US$18M (−3.6% year on year).
Earnings · Aug 12 - Share-pledge agreement that may change the largest shareholder
Classys's largest shareholder (BCPE Centur Investments,LP) pledged shares as loan collateral to a financial company, securing up to US$614M.
Ownership change · Jun 26 - Share-pledge agreement that may change the largest shareholder
Classys's largest shareholder (BCPE Centur Investments,LP) pledged shares as loan collateral, securing up to US$491M.
Ownership change · Jun 26 - Share-pledge agreement that may change the largest shareholder
Classys's largest shareholder (BCPE Centur Investments,LP) pledged shares as loan collateral, securing up to US$262M.
Ownership change · Jun 26 - Operating results (consolidated) (preliminary) (fair disclosure)
Classys filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$58.5M (+13% year on year), operating profit of US$25M (−4.1% year on year) and net income of US$22.3M (+11.5% year on year).
Earnings · May 13 - Cash/in-kind dividend decision
Classys declared a cash dividend of US$0.68 per share, equal to about 1.8% of the recent share price.
Dividend · Mar 13 - [Amended] Decision to acquire shares/equity in another company (voluntary) (subsidiary)
Classys updated the disclosed terms of a subsidiary's acquisition of JL Health Participacoes S.A., now worth US$11.4M.
M&A · Mar 10 - [Amended] Decision to acquire shares/equity in another company (voluntary) (subsidiary)
Classys updated the disclosed terms of a subsidiary's acquisition of JL Health Participacoes S.A., now worth US$11.4M.
M&A · Mar 5 - [Amended] Decision to acquire shares/equity in another company
Classys updated the disclosed terms of an acquisition of Classys Brasil Ltda., now worth US$16.2M.
M&A · Feb 27 · 2 versions - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Classys reported consolidated results for FY2025: revenue of US$234M (+38.6% year on year), operating profit of US$118M (+39.3% year on year) and net income of US$91.6M (+35.2% year on year).
Earnings · Feb 13 - Operating results (consolidated) (preliminary) (fair disclosure)
Classys filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$64.8M (+25.6% year on year), operating profit of US$35.5M (+43% year on year) and net income of US$29.6M (+50.3% year on year).
Earnings · Feb 13 - [Amended] Material event report (treasury share disposal)Treasury Shares · Jan 9
- Material event report (treasury share disposal)Treasury Shares · Jan 9